For research use only. Not for therapeutic Use.
PI3K-IN-36 (compound A36) is a potent PI3K inhibitor. PI3K-IN-36 can be used in research of follicular lymphoma (FL)[1].
Catalog Number | I042617 |
CAS Number | 1401436-93-8 |
Synonyms | 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-(2-piperidin-4-ylphenyl)propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine |
Molecular Formula | C30H36F2N8O |
Purity | ≥95% |
InChI | InChI=1S/C30H36F2N8O/c1-30(2,19-21-7-3-4-8-22(21)20-11-13-33-14-12-20)38-27-35-28(39-15-17-41-18-16-39)37-29(36-27)40-24-10-6-5-9-23(24)34-26(40)25(31)32/h3-10,20,25,33H,11-19H2,1-2H3,(H,35,36,37,38) |
InChIKey | YLLUIILPJZBRRN-UHFFFAOYSA-N |
SMILES | CC(C)(CC1=CC=CC=C1C2CCNCC2)NC3=NC(=NC(=N3)N4CCOCC4)N5C6=CC=CC=C6N=C5C(F)F |
Reference | [1]. Gold DP. Treatment of relapsed follicular lymphoma. WO2020036997. |